The mood of the global markets turned jittery as global growth concerns returned to haunt the markets and also, reports indicated that President Donald Trump did not expect to meet his Chinese counterpart Xi Jinping before the March deadline for trade war negotiations. Considering these factors, we may see initial weakness in the Indian markets. The SGX Nifty suggests that Nifty may open around 11,073, down by 21 points. Some of the key stocks such as BPCL, Engineers India, M&M, REC and Tata Steel will announce their quarterly earnings. 

For the quarter ended December 2018, Tata Motors reported staggering losses of Rs. 26,992.54 crore as its luxury car unit, Jaguar Land Rover (JLR) continued to struggle.

The company reported a PAT of Rs. 11.35 crore with an EPS of Rs. 3.63 for the quarter ended December 2018 as against Rs. 18.83 crore with an EPS of Rs. 6.02 per share for the corresponding quarter last year, registering a degrowth of 39.72 per cent per cent.

The PAT for the quarter came in at Rs. 63.92 crore, yoy increase of 73.6 per cent. Finance cost for the quarter jumped 132 per cent yoy to Rs. 33.3 crore. 

Much of the bitcoin, cryptocurrency frenzy had fizzled out in 2018, but many investors or so-called early adopters still hold hope in the phenomenon dubbed as the currency of the digital age. Now there is a major twist in the cryptocurrency tale and all that happened very close to us, read on to know.

Manappuram Finance Limited has declared a good set of numbers for third quarter FY19. Shares of Mannappuram reached an intraday high of Rs. 104.15 per share on the BSE on Thursday.  

In asset allocation, 100 minus age is one of the basic thumb rules. Let’s find out if this rule is valid in today’s circumstances?

Pharma major Glenmark was granted tentative USFDA approval for Fulvestrant Injection, 250 mg/5 ml. The shares of the company experienced volatility on an intraday basis.